| Nazneen Saba Hussain, MD | |
|
16777 Medical Center Dr, Baton Rouge, LA 70816 | |
| (225) 761-5200 | |
| Not Available |
| Full Name | Nazneen Saba Hussain |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 11 Years |
| Location | 16777 Medical Center Dr, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336583509 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD.301675 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ochsner Medical Center - Baton Rouge | Baton rouge, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
University at Buffalo smoking cessation researchers today applauded federal plans to require cigarette packs and ads to carry bigger, much more prominent and graphic health warnings, including images of the destruction to the lungs caused by tobacco, which must cover half of a cigarette pack. In announcing the initiative, the Health and Human Services Department called the new warnings "the most significant change in more than 25 years" in cigarette packages and advertising.
Their work on targeting individual genes for more effective and cheaper drug testing opens the way to treatments for a huge range of diseases including diabetes and atherosclerosis, which leads to strokes and heart attacks.
Researchers and scientists of the Charité - Universitätsmedizin Berlin, in cooperation with the Max Delbrück Center for Molecular Medicine, and colleagues from the Netherlands, Belgium, Switzerland and the Czech Republic have succeeded in identifying a genetic cause of magnesium deficiency.
The FRS Company, a developer and distributor of FRS® Healthy Energy® products, announced today that it has received $23.1 million in its latest financing round led by Oak Investment Partners, LLC. Oak Investment Partners was an early investor in The FRS Company, and its continued support of FRS validates the company's aggressive business strategy for national and international expansion and explosive sales growth.
PrognostiX, a start-up company based on Cleveland Clinic technology, has received approval from the U.S. Food and Drug Administration to begin selling a diagnostic test capable of identifying patients who are in imminent danger of heart attack or death.
› Verified 7 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
University at Buffalo smoking cessation researchers today applauded federal plans to require cigarette packs and ads to carry bigger, much more prominent and graphic health warnings, including images of the destruction to the lungs caused by tobacco, which must cover half of a cigarette pack. In announcing the initiative, the Health and Human Services Department called the new warnings "the most significant change in more than 25 years" in cigarette packages and advertising.
Their work on targeting individual genes for more effective and cheaper drug testing opens the way to treatments for a huge range of diseases including diabetes and atherosclerosis, which leads to strokes and heart attacks.
Researchers and scientists of the Charité - Universitätsmedizin Berlin, in cooperation with the Max Delbrück Center for Molecular Medicine, and colleagues from the Netherlands, Belgium, Switzerland and the Czech Republic have succeeded in identifying a genetic cause of magnesium deficiency.
The FRS Company, a developer and distributor of FRS® Healthy Energy® products, announced today that it has received $23.1 million in its latest financing round led by Oak Investment Partners, LLC. Oak Investment Partners was an early investor in The FRS Company, and its continued support of FRS validates the company's aggressive business strategy for national and international expansion and explosive sales growth.
PrognostiX, a start-up company based on Cleveland Clinic technology, has received approval from the U.S. Food and Drug Administration to begin selling a diagnostic test capable of identifying patients who are in imminent danger of heart attack or death.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nazneen Saba Hussain, MD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-4000 | Nazneen Saba Hussain, MD 16777 Medical Center Dr, Baton Rouge, LA 70816 Ph: (225) 761-5200 |
News Archive
University at Buffalo smoking cessation researchers today applauded federal plans to require cigarette packs and ads to carry bigger, much more prominent and graphic health warnings, including images of the destruction to the lungs caused by tobacco, which must cover half of a cigarette pack. In announcing the initiative, the Health and Human Services Department called the new warnings "the most significant change in more than 25 years" in cigarette packages and advertising.
Their work on targeting individual genes for more effective and cheaper drug testing opens the way to treatments for a huge range of diseases including diabetes and atherosclerosis, which leads to strokes and heart attacks.
Researchers and scientists of the Charité - Universitätsmedizin Berlin, in cooperation with the Max Delbrück Center for Molecular Medicine, and colleagues from the Netherlands, Belgium, Switzerland and the Czech Republic have succeeded in identifying a genetic cause of magnesium deficiency.
The FRS Company, a developer and distributor of FRS® Healthy Energy® products, announced today that it has received $23.1 million in its latest financing round led by Oak Investment Partners, LLC. Oak Investment Partners was an early investor in The FRS Company, and its continued support of FRS validates the company's aggressive business strategy for national and international expansion and explosive sales growth.
PrognostiX, a start-up company based on Cleveland Clinic technology, has received approval from the U.S. Food and Drug Administration to begin selling a diagnostic test capable of identifying patients who are in imminent danger of heart attack or death.
› Verified 7 days ago
Dr. Jennifer L Rippon, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd Ste 409, Baton Rouge, LA 70808 Phone: 225-765-5864 Fax: 225-765-2013 | |
Gregory Fusilier, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 9103 Jefferson Hwy, Baton Rouge, LA 70809 Phone: 225-927-1190 Fax: 225-927-0988 | |
Dr. Yolanda Maria O'rourke, Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 7968 Essen Park, Baton Rouge, LA 70809 Phone: 225-761-6700 Fax: 225-761-6760 | |
Patricia D. Whatley, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 7373 Perkins Rd, Attn: Dee / Administration, Baton Rouge, LA 70808 Phone: 225-769-4044 | |
Frederick Cerise, Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3810 W Lakeshore Dr, Baton Rouge, LA 70808 Phone: 225-578-8886 | |
Dr. Jon Richard Jackson, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5000 Hennessy Blvd, Baton Rouge, LA 70808 Phone: 225-765-4050 Fax: 225-765-4046 | |
Richard Frank Burroughs, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: Earl K. Long Hospital, Lsu Unit, 5825 Airline Highway, Baton Rouge, LA 70805 Phone: 225-358-3938 |